(HSY) Hershey - Overview
Stock: Chocolate, Confectionery, Snacks, Gum, Pantry
| Risk 5d forecast | |
|---|---|
| Volatility | 31.1% |
| Relative Tail Risk | -3.54% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.13 |
| Alpha | 34.68 |
| Character TTM | |
|---|---|
| Beta | 0.071 |
| Beta Downside | 0.048 |
| Drawdowns 3y | |
|---|---|
| Max DD | 45.25% |
| CAGR/Max DD | 0.01 |
EPS (Earnings per Share)
Revenue
Description: HSY Hershey January 28, 2026
The Hershey Company (HSY) manufactures and sells a broad portfolio of confectionery, salty-snack, and pantry products across three operating segments-North America Confectionery, North America Salty Snacks, and International-serving wholesale, retail, and food-service channels in roughly 80 countries.
In the most recent quarter (Q2 FY2024), Hershey reported net sales of $3.20 billion, up 5.1 % year-over-year, driven primarily by price-realization gains that offset modest volume softness; operating margin expanded to 16.2 % (vs. 15.4 % a year ago) and diluted earnings per share reached $2.70. The company’s “ONE Bar” protein-snack line grew at a 14 % compound annual rate since launch, while its “SkinnyPop” popcorn brand posted a 9 % sales increase in the quarter.
Key macro drivers include persistent inflation in cocoa and sugar commodities (the Bloomberg Cocoa Index has risen ~12 % YTD), which pressures input costs, and a broader consumer shift toward higher-protein and lower-sugar snack options that is expanding the total addressable market for Hershey’s non-chocolate categories. At the same time, discretionary spending trends remain sensitive to real-wage growth and employment stability, factors that can moderate demand for premium confectionery.
For a deeper, data-driven assessment of Hershey’s valuation and risk profile, a quick look at the company’s metrics on ValueRay may uncover additional insights worth exploring.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 883.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 0.16 > 1.0 |
| NWC/Revenue: 4.93% < 20% (prev -1.52%; Δ 6.45% < -1%) |
| CFO/TA 0.17 > 3% & CFO 2.28b > Net Income 883.3m |
| Net Debt (4.48b) to EBITDA (1.76b): 2.55 < 3 |
| Current Ratio: 1.19 > 1.5 & < 3 |
| Outstanding Shares: last quarter (203.3m) vs 12m ago -0.11% < -2% |
| Gross Margin: 33.27% > 18% (prev 0.47%; Δ 3280 % > 0.5%) |
| Asset Turnover: 87.62% > 50% (prev 86.52%; Δ 1.10% > 0%) |
| Interest Coverage Ratio: 4.84 > 6 (EBITDA TTM 1.76b / Interest Expense TTM 207.4m) |
Altman Z'' 2.74
| A: 0.04 (Total Current Assets 3.59b - Total Current Liabilities 3.01b) / Total Assets 13.74b |
| B: 0.40 (Retained Earnings 5.50b / Total Assets 13.74b) |
| C: 0.08 (EBIT TTM 1.00b / Avg Total Assets 13.34b) |
| D: 0.63 (Book Value of Equity 5.72b / Total Liabilities 9.10b) |
| Altman-Z'' Score: 2.74 = A |
Beneish M -2.73
| DSRI: 0.87 (Receivables 729.5m/800.4m, Revenue 11.69b/11.20b) |
| GMI: 1.42 (GM 33.27% / 47.32%) |
| AQI: 1.16 (AQ_t 0.48 / AQ_t-1 0.42) |
| SGI: 1.04 (Revenue 11.69b / 11.20b) |
| TATA: -0.10 (NI 883.3m - CFO 2.28b) / TA 13.74b) |
| Beneish M-Score: -2.73 (Cap -4..+1) = A |
What is the price of HSY shares?
Over the past week, the price has changed by +1.08%, over one month by +17.09%, over three months by +20.14% and over the past year by +28.53%.
Is HSY a buy, sell or hold?
- StrongBuy: 3
- Buy: 1
- Hold: 17
- Sell: 2
- StrongSell: 2
What are the forecasts/targets for the HSY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 228.1 | 2.9% |
| Analysts Target Price | 228.1 | 2.9% |
HSY Fundamental Data Overview February 21, 2026
P/E Forward = 28.9017
P/S = 3.8139
P/B = 9.7344
P/EG = 48.5713
Revenue TTM = 11.69b USD
EBIT TTM = 1.00b USD
EBITDA TTM = 1.76b USD
Long Term Debt = 4.68b USD (from longTermDebt, last quarter)
Short Term Debt = 721.9m USD (from shortTermDebt, last quarter)
Debt = 5.40b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.48b USD (from netDebt column, last quarter)
Enterprise Value = 49.07b USD (44.59b + Debt 5.40b - CCE 925.9m)
Interest Coverage Ratio = 4.84 (Ebit TTM 1.00b / Interest Expense TTM 207.4m)
EV/FCF = 23.76x (Enterprise Value 49.07b / FCF TTM 2.07b)
FCF Yield = 4.21% (FCF TTM 2.07b / Enterprise Value 49.07b)
FCF Margin = 17.67% (FCF TTM 2.07b / Revenue TTM 11.69b)
Net Margin = 7.55% (Net Income TTM 883.3m / Revenue TTM 11.69b)
Gross Margin = 33.27% ((Revenue TTM 11.69b - Cost of Revenue TTM 7.80b) / Revenue TTM)
Gross Margin QoQ = 37.04% (prev 31.58%)
Tobins Q-Ratio = 3.57 (Enterprise Value 49.07b / Total Assets 13.74b)
Interest Expense / Debt = 0.89% (Interest Expense 48.1m / Debt 5.40b)
Taxrate = 13.40% (49.5m / 369.5m)
NOPAT = 869.5m (EBIT 1.00b * (1 - 13.40%))
Current Ratio = 1.19 (Total Current Assets 3.59b / Total Current Liabilities 3.01b)
Debt / Equity = 1.17 (Debt 5.40b / totalStockholderEquity, last quarter 4.64b)
Debt / EBITDA = 2.55 (Net Debt 4.48b / EBITDA 1.76b)
Debt / FCF = 2.17 (Net Debt 4.48b / FCF TTM 2.07b)
Total Stockholder Equity = 4.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.62% (Net Income 883.3m / Total Assets 13.74b)
RoE = 19.20% (Net Income TTM 883.3m / Total Stockholder Equity 4.60b)
RoCE = 10.82% (EBIT 1.00b / Capital Employed (Equity 4.60b + L.T.Debt 4.68b))
RoIC = 8.49% (NOPAT 869.5m / Invested Capital 10.24b)
WACC = 5.60% (E(44.59b)/V(50.00b) * Re(6.18%) + D(5.40b)/V(50.00b) * Rd(0.89%) * (1-Tc(0.13)))
Discount Rate = 6.18% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.51%
[DCF Debug] Terminal Value 86.74% ; FCFF base≈2.01b ; Y1≈2.09b ; Y5≈2.41b
Fair Price DCF = 452.8 (EV 71.57b - Net Debt 4.48b = Equity 67.09b / Shares 148.2m; r=5.90% [WACC]; 5y FCF grow 4.52% → 2.90% )
EPS Correlation: -47.30 | EPS CAGR: -9.92% | SUE: 1.50 | # QB: 3
Revenue Correlation: 34.38 | Revenue CAGR: 4.02% | SUE: 0.94 | # QB: 1
EPS next Quarter (2026-03-31): EPS=2.04 | Chg30d=+0.222 | Revisions Net=+11 | Analysts=17
EPS current Year (2026-12-31): EPS=8.36 | Chg30d=+1.380 | Revisions Net=+19 | Growth EPS=+32.5% | Growth Revenue=+4.3%
EPS next Year (2027-12-31): EPS=9.73 | Chg30d=+1.528 | Revisions Net=+12 | Growth EPS=+16.3% | Growth Revenue=+2.5%